Empery Asset Management LP 13D and 13G filings for Hepion Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-19 10:48 am Sale | 2021-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Empery Asset Management LP | 16,787 0.440% | -183,213 (-91.61%) | Filing |
| 2021-02-18 10:49 am Purchase | 2021-02-16 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Empery Asset Management LP | 200,000 5.250% | 183,213 (+1091.38%) | Filing |
| 2021-01-20 11:10 am Sale | 2020-12-31 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Empery Asset Management LP | 16,787 1.050% | -83,213 (-83.21%) | Filing |
| 2020-12-02 11:12 am Purchase | 2020-11-25 | 13G | Hepion Pharmaceuticals, Inc. HEPA | Empery Asset Management LP | 100,000 6.910% | 100,000 (New Position) | Filing |